Targeted imaging and therapeutics is becoming a field of prime importance in the study and treatment of cardiovascular disease; it promises to enable early diagnosis, promote improved understanding of pathology, and offer a way to improve therapeutic efficacy. Agents, particularly for cardiovascular disease, have been reported to permit the in vivo imaging, by multiple modalities, of macrophages, vascular targets such as vascular cell adhesion molecule 1, and markers for angiogenesis such as αvβ3 integrin. In this Article, we first discuss the general concept of multimodality nanoparticles and then focus in greater depth on their clinical application for molecular imaging and therapy. Lastly, several examples of cardiovascular applications are discussed, including combined imaging and therapy approaches.

Original languageEnglish
Pages (from-to)S103-S111
JournalNature Clinical Practice Cardiovascular Medicine
Issue numberSUPPL. 2
StatePublished - Aug 2008


Dive into the research topics of 'Multimodality nanotracers for cardiovascular applications'. Together they form a unique fingerprint.

Cite this